New directions in monoamine oxidase A and B selective inhibitors and substrates
- 1 January 1991
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (2) , 155-162
- https://doi.org/10.1016/0006-2952(91)90471-g
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- The Novel Neuropsychotropic Agent Milacemide Is a Specific Enzyme‐Activated Inhibitor of Brain Monoamine Oxidase BJournal of Neurochemistry, 1989
- A and B Forms of Monoamine Oxidase Within the Monoaminergic Neurons of the Rat BrainJournal of Neurochemistry, 1986
- An update on the identity crisis of monoamine oxidase: new and old evidence for the independence of mao A and BPharmacology & Therapeutics, 1985
- Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Isolated Chromaffin Cells from Adrenal Medulla Contain Primarily Monoamine Oxidase BScience, 1984
- L-deprenyl plus l-phenylalanine in the treatment of depressionJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1984
- Monoamine oxidase -A and -B activity in the rat brain after hemitransectionLife Sciences, 1980
- Anti-depressant potentiation of 5-hydroxytryptophan by L-deprenyl, an MAO ?type B? inhibitorJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975